Michael C. Milone
Assistant Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania
Staff Physician, Department of Pathology and Laboratory Medicine
Department: Pathology and Laboratory Medicine
Contact information
3400 Spruce Street 7103 Founders Pavilion
Philadelphia, PA 19104
Philadelphia, PA 19104
Office: 215-662-6575
Fax: 215-662-7529
Fax: 215-662-7529
Email:
milone@mail.med.upenn.edu
milone@mail.med.upenn.edu
Graduate Group Affiliations
Education:
B.S (Chemical Biology)
Stevens Institute of Technology, 1993.
Ph.D (Experimental Pathology/ Immunology)
UMDNJ - Graduate School of Biomedical Sciences, 1999.
M.D. (Medical Doctor)
UMDNJ- New Jersey Medical School, 1999.
B.S (Chemical Biology)
Stevens Institute of Technology, 1993.
Ph.D (Experimental Pathology/ Immunology)
UMDNJ - Graduate School of Biomedical Sciences, 1999.
M.D. (Medical Doctor)
UMDNJ- New Jersey Medical School, 1999.
Links
NIH common fund description of our nanomedicine research effort.
Website for nanomedicine development center
Permanent linkNIH common fund description of our nanomedicine research effort.
Website for nanomedicine development center
Description of Research Expertise
Research in my laboratory aims toward improving cancer and transplantation therapy through the development of new immunotherapeutic modalities and diagnostic assays of immune cell function. Active research projects in my laboratory include:1) Developing improved chimeric antigen receptors (CARs) for adoptive immunotherapy of cancer.
This project is focused upon understanding the mechanisms of signal transduction of artificial T cell antigen receptors through traditional biochemical studies along with high resolution dynamic imaging of artificial and natural T cell receptors. New CAR designs are also under development to permit more controlled activation of T cells.
2) Developing novel T cell stimulatory substrates based upon nano- and micro-fabricated surfaces for control of T cell proliferation and differentiation.
This project is part of a collaborative effort supported by the NIH roadmap initiative that aims to translate work of several center investigators into clinically-useful systems for T cell expansion to adoptive immunotherapy. Details of this project can be found at the center's website (www.mechanicalbiology.org) or the NIH common fund site (http://commonfund.nih.gov/nanomedicine/devcenters/mechanicalbiology.asp)
